Evotec SE Statistics

Total Valuation

Evotec SE has a market cap or net worth of GBP 1.20 billion. The enterprise value is 1.34 billion.

Market Cap	1.20B
Enterprise Value	1.34B

Important Dates

The next estimated earnings date is Friday, April 11, 2025.

Earnings Date	Apr 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.20%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	128.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 60.21, with an EV/FCF ratio of -7.99.

EV / Earnings	-9.40
EV / Sales	2.04
EV / EBITDA	60.21
EV / EBIT	n/a
EV / FCF	-7.99

Financial Position

The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.49.

Current Ratio	2.09
Quick Ratio	1.59
Debt / Equity	0.49
Debt / EBITDA	12.71
Debt / FCF	-2.33
Interest Coverage	-5.75

Financial Efficiency

Return on equity (ROE) is -16.25% and return on invested capital (ROIC) is -2.37%.

Return on Equity (ROE)	-16.25%
Return on Assets (ROA)	-1.77%
Return on Capital (ROIC)	-2.37%
Revenue Per Employee	129,143
Profits Per Employee	-28,481
Employee Count	5,061
Asset Turnover	0.37
Inventory Turnover	19.82

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.95% in the last 52 weeks. The beta is 0.98, so Evotec SE's price volatility has been similar to the market average.

Beta (5Y)	0.98
52-Week Price Change	-43.95%
50-Day Moving Average	8.67
200-Day Moving Average	8.22
Relative Strength Index (RSI)	42.70
Average Volume (20 Days)	54,026

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Evotec SE had revenue of GBP 646.62 million and -142.60 million in losses. Loss per share was -0.80.

Revenue	646.62M
Gross Profit	88.58M
Operating Income	-50.05M
Pretax Income	-168.21M
Net Income	-142.60M
EBITDA	13.23M
EBIT	-50.05M
Loss Per Share	-0.80

Full Income Statement

Balance Sheet

The company has 252.37 million in cash and 391.15 million in debt, giving a net cash position of -138.78 million.

Cash & Cash Equivalents	252.37M
Total Debt	391.15M
Net Cash	-138.78M
Net Cash Per Share	n/a
Equity (Book Value)	805.91M
Book Value Per Share	4.54
Working Capital	303.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -30.00 million and capital expenditures -137.83 million, giving a free cash flow of -167.83 million.

Operating Cash Flow	-30.00M
Capital Expenditures	-137.83M
Free Cash Flow	-167.83M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 13.70%, with operating and profit margins of -7.74% and -22.05%.

Gross Margin	13.70%
Operating Margin	-7.74%
Pretax Margin	-26.01%
Profit Margin	-22.05%
EBITDA Margin	2.05%
EBIT Margin	-7.74%
FCF Margin	n/a

Dividends & Yields

Evotec SE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.20%
Shareholder Yield	-0.20%
Earnings Yield	-11.89%
FCF Yield	-13.99%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Evotec SE has an Altman Z-Score of 1.37. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.37
Piotroski F-Score	n/a